Stocks Move Lower As Earnings Disappoint-Market Analysis: January 13th, 2026

Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.

Here’s What Lifted Johnson & Johnson (JNJ) in Q4

Mar Vista U.S. Quality Strategy stated the following regarding Johnson & Johnson (NYSE:JNJ) in its fourth quarter 2025 ...

JPMorgan Chase beat largely due to lower expenses, analysts say

JPMorgan Chase ( JPM) stock slid 4.0% in Tuesday afternoon trading as the bank's Q4 earnings beat consensus, largely on lower ...

7MM Autism Spectrum Disorder Market Opportunity Assessment and Forecast Report 2024-2034: Entry of the Five Pipeline Products Will Have a Significant Impact on the Market

The ASD market holds significant opportunities due to unmet needs for targeted treatments, given no approved therapies for core symptoms exist. With three late-stage developments and the expected ...

Increased Clarity on Drug Pricing and Tariffs Led to a Healthcare Rebound; Sector Looks Fairly Valued

The Morningstar Healthcare Index slightly lagged the Morningstar US Index, with a total return of 15.2% in 2025, compared with 17.4% for the Morningstar US Index.
WahanaRiau.com

Zymeworks Outlines Strategic Priorities and Outlook for 2026

Positive Phase 3 HERIZON-GEA-01 results for Ziihera® (zanidatamab-hrii) in first-line HER2-positive (HER2+) gastroesophageal ...